高级检索
    黄诚. 帕博利珠单抗联合化疗在PD-L1阴性晚期非小细胞肺癌中的汇总分析[J]. 循证医学, 2021, 21(4): 214-219. DOI: 10.12019/j.issn.1671-5144.2021.04.005
    引用本文: 黄诚. 帕博利珠单抗联合化疗在PD-L1阴性晚期非小细胞肺癌中的汇总分析[J]. 循证医学, 2021, 21(4): 214-219. DOI: 10.12019/j.issn.1671-5144.2021.04.005
    shu
    HUANG Cheng. Pooled Analysis of Pembrolizumab Plus Chemotherapy in Advanced Non-Small Cell Lung Cancer Patients Without Tumor PD-L1 Expression[J]. Journal of Evidence-Based Medicine, 2021, 21(4): 214-219. DOI: 10.12019/j.issn.1671-5144.2021.04.005
    Citation: HUANG Cheng. Pooled Analysis of Pembrolizumab Plus Chemotherapy in Advanced Non-Small Cell Lung Cancer Patients Without Tumor PD-L1 Expression[J]. Journal of Evidence-Based Medicine, 2021, 21(4): 214-219. DOI: 10.12019/j.issn.1671-5144.2021.04.005
    shu

    帕博利珠单抗联合化疗在PD-L1阴性晚期非小细胞肺癌中的汇总分析

    Pooled Analysis of Pembrolizumab Plus Chemotherapy in Advanced Non-Small Cell Lung Cancer Patients Without Tumor PD-L1 Expression

      摘要
      • HTML全文
      • 参考文献(10)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回